The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
18 02 2022
Historique:
entrez: 18 2 2022
pubmed: 19 2 2022
medline: 20 4 2022
Statut: ppublish

Résumé

The contribution of epigenetic dysregulation to metastasis remains understudied. Through a meta-analysis of gene expression datasets followed by a mini-screen, we identified Plant Homeodomain Finger protein 8 (PHF8), a histone demethylase of the Jumonji C protein family, as a previously unidentified prometastatic gene in melanoma. Loss- and gain-of-function approaches demonstrate that PHF8 promotes cell invasion without affecting proliferation in vitro and increases dissemination but not subcutaneous tumor growth in vivo, thus supporting its specific contribution to the acquisition of metastatic potential. PHF8 requires its histone demethylase activity to enhance melanoma cell invasion. Transcriptomic and epigenomic analyses revealed that PHF8 orchestrates a molecular program that directly controls the TGFβ signaling pathway and, as a consequence, melanoma invasion and metastasis. Our findings bring a mechanistic understanding of epigenetic regulation of metastatic fitness in cancer, which may pave the way for improved therapeutic interventions.

Identifiants

pubmed: 35179962
doi: 10.1126/sciadv.abi7127
pmc: PMC8856617
doi:

Substances chimiques

Homeodomain Proteins 0
Transcription Factors 0
Transforming Growth Factor beta 0
Histone Demethylases EC 1.14.11.-
PHF8 protein, human EC 1.14.11.-

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabi7127

Subventions

Organisme : NCI NIH HHS
ID : R01 CA202027
Pays : United States

Références

J Clin Invest. 2016 Jun 1;126(6):2205-20
pubmed: 27183383
PLoS One. 2010 May 24;5(5):e10770
pubmed: 20520718
Mol Cancer Res. 2008 May;6(5):760-9
pubmed: 18505921
Cancer Cell. 2005 Nov;8(5):369-80
pubmed: 16286245
J Exp Clin Cancer Res. 2018 Sep 4;37(1):215
pubmed: 30180906
Nat Rev Cancer. 2009 Nov;9(11):773-84
pubmed: 19851313
Nat Rev Drug Discov. 2013 Dec;12(12):917-30
pubmed: 24232376
Nat Commun. 2015 Apr 09;6:6683
pubmed: 25865119
Science. 2011 Mar 25;331(6024):1559-64
pubmed: 21436443
Br J Cancer. 1998 May;77(9):1492-4
pubmed: 9652767
Nature. 2018 Feb 22;554(7693):544-548
pubmed: 29443960
Nat Rev Mol Cell Biol. 2018 Jul;19(7):419-435
pubmed: 29643418
Oncotarget. 2016 Nov 15;7(46):75585-75602
pubmed: 27689328
Oncogene. 2012 Jul 19;31(29):3444-56
pubmed: 22120715
Mol Cell. 2017 Nov 16;68(4):731-744.e9
pubmed: 29149598
Pigment Cell Melanoma Res. 2008 Apr;21(2):123-32
pubmed: 18426405
Cancer Cell. 2013 Jun 10;23(6):811-25
pubmed: 23764003
Cell Death Dis. 2011 Sep 01;2:e204
pubmed: 21881606
Cell. 2018 Apr 5;173(2):371-385.e18
pubmed: 29625053
Ann Oncol. 2010 Dec;21(12):2361-2369
pubmed: 20444850
Pigment Cell Res. 2006 Aug;19(4):290-302
pubmed: 16827748
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24859-24866
pubmed: 32958674
Clin Cancer Res. 2005 Oct 15;11(20):7234-42
pubmed: 16243793
Nat Struct Mol Biol. 2010 Jan;17(1):38-43
pubmed: 20023638
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nature. 2016 Jan 21;529(7586):298-306
pubmed: 26791720
Nat Rev Cancer. 2003 Nov;3(11):807-21
pubmed: 14557817
Nucleic Acids Res. 2017 Feb 28;45(4):1687-1702
pubmed: 27899639
Genes Dev. 2016 Jan 1;30(1):18-33
pubmed: 26679841
Cancer Res. 2008 Feb 1;68(3):650-6
pubmed: 18245463
Cancer Res. 2008 Jun 15;68(12):4500-5
pubmed: 18559492
Oncoimmunology. 2016 Dec 7;6(1):e1257453
pubmed: 28197376
Mol Cell. 2010 Apr 23;38(2):165-78
pubmed: 20346720
Cell Rep. 2017 Oct 10;21(2):455-466
pubmed: 29020631
BMC Med Genomics. 2008 Apr 28;1:13
pubmed: 18442402
Nature. 2018 Feb 22;554(7693):538-543
pubmed: 29443964
Development. 2013 Jun;140(12):2525-34
pubmed: 23715546
Expert Opin Ther Pat. 2016 Dec;26(12):1367-1370
pubmed: 27730846
Cancer Res. 2008 Jun 1;68(11):4248-57
pubmed: 18519684
Cell. 2015 Jun 18;161(7):1681-96
pubmed: 26091043
BMC Genomics. 2017 Jun 5;18(1):434
pubmed: 28583068
Nat Rev Mol Cell Biol. 2012 Apr 04;13(5):297-311
pubmed: 22473470
Oncogenesis. 2016 Dec 19;5(12):e283
pubmed: 27991916
Cell. 2010 May 14;141(4):583-94
pubmed: 20478252
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nature. 2010 Jul 22;466(7305):508-12
pubmed: 20622854
Biochem Biophys Res Commun. 2018 Feb 12;496(3):981-987
pubmed: 29330049
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell. 2012 Jul 20;150(2):251-63
pubmed: 22817889
J Invest Dermatol. 2014 Jun;134(6):1675-1685
pubmed: 24499734
Nature. 2010 Jul 22;466(7305):503-7
pubmed: 20622853
Melanoma Res. 2012 Jun;22(3):184-94
pubmed: 22454190
Onco Targets Ther. 2015 Aug 10;8:1979-88
pubmed: 26309412
Cancer Res. 2017 Jan 15;77(2):448-458
pubmed: 27815389
Cancer Discov. 2015 Dec;5(12):1314-27
pubmed: 26450788
Nature. 2014 Apr 3;508(7494):118-22
pubmed: 24670642
Mol Med Rep. 2017 Oct;16(4):4437-4444
pubmed: 28765946
Mol Cell Biol. 2006 Apr;26(7):2560-9
pubmed: 16537902
J Zhejiang Univ Sci B. 2014 May;15(5):412-28
pubmed: 24793759

Auteurs

Rana S Moubarak (RS)

Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.
Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.
Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA.

Ana de Pablos-Aragoneses (A)

Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.

Vanessa Ortiz-Barahona (V)

Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.

Yixiao Gong (Y)

Applied Bioinformatics Laboratories, NYU School of Medicine, NY 10016, USA.

Michael Gowen (M)

NYU School of Medicine Institute for Computational Medicine, New York, NY 10016, USA.

Igor Dolgalev (I)

Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.
Applied Bioinformatics Laboratories, NYU School of Medicine, NY 10016, USA.

Sorin A A Shadaloey (SAA)

Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.
Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.

Diana Argibay (D)

Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.
Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.

Alcida Karz (A)

Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.
Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.

Richard Von Itter (R)

Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.
Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.

Eleazar Carmelo Vega-Sáenz de Miera (EC)

NYU School of Medicine Institute for Computational Medicine, New York, NY 10016, USA.

Elena Sokolova (E)

Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.
Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.

Farbod Darvishian (F)

Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.
Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.

Aristotelis Tsirigos (A)

Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.
Applied Bioinformatics Laboratories, NYU School of Medicine, NY 10016, USA.
NYU School of Medicine Institute for Computational Medicine, New York, NY 10016, USA.

Iman Osman (I)

Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.
Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA.
Ronald O. Perelman Department of Dermatology, NYU School of Medicine, New York, NY 10016, USA.

Eva Hernando (E)

Department of Pathology, NYU School of Medicine, New York, NY 10016, USA.
Interdisciplinary Melanoma Cooperative Group, NYU Cancer Institute, New York, NY 10016, USA.
Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH